Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.

Autor: Dixon EP; BD Diagnostics - Women's Health and Cancer, Durham, NC, USA. Electronic address: Eric_Dixon@BD.com., King LM; BD Diagnostics - Women's Health and Cancer, Durham, NC, USA., Nelson R; BD Diagnostics - Women's Health and Cancer, Durham, NC, USA., Simkins SG; BD Diagnostics - Women's Health and Cancer, Durham, NC, USA., Knapp SL; BD Diagnostics - Women's Health and Cancer, Durham, NC, USA., Brough GH; BD Diagnostics - Women's Health and Cancer, Durham, NC, USA., Lenz KL; BD Diagnostics - Women's Health and Cancer, Durham, NC, USA., Henderson DT; BD Diagnostics - Women's Health and Cancer, Durham, NC, USA., Whitehead CM; BD Diagnostics - Women's Health and Cancer, Durham, NC, USA., Hessling J; Solstas Lab Partners, Greensboro, NC, USA., Brown CA; BD Diagnostics - Women's Health and Cancer, Durham, NC, USA., Malinowski DP; BD Diagnostics - Women's Health and Cancer, Durham, NC, USA.

Publikováno v: Journal of immunological methods [J Immunol Methods] 2017 Mar; Vol. 442, pp. 35-41. Date of Electronic Publication: 2017 Jan 16.